• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌肝移植中的精准医学:第三代测序技术的应用与前景

Precision medicine in liver transplantation for hepatocellular carcinoma: applications and prospects of third-generation sequencing technology.

作者信息

Tian Ye, Wang Xiaojuan, Lu Qian

机构信息

Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, 102218, Beijing, China.

Institute for Organ Transplant and Bionic Medicine, Beijing Key Laboratory of Liver Transplantation and Bionic Manufacturing, Tsinghua University, 102218, Beijing, China.

出版信息

J Cancer Res Clin Oncol. 2025 Sep 13;151(9):257. doi: 10.1007/s00432-025-06299-3.

DOI:10.1007/s00432-025-06299-3
PMID:40944711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12433387/
Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Liver transplantation (LT) remains a vital treatment for HCC, yet it still faces numerous challenges in patient selection, recurrence monitoring, and personalized therapy. Third-generation sequencing (TGS), with its advantages of long read length, high throughput, direct detection of epigenetic modifications, real-time analysis and high accuracy, offers promise for advancing precision medicine in LT. While previous reviews have focused on TGS technical features, this review uniquely synthesizes its role in addressing specific clinical challenges in LT-HCC management and critically assesses its translational pathway. Specifically, it systematically examines TGS applications in candidate screening, recurrence monitoring, and personalized therapy for LT-HCC, analyzes its prospects for clinical translation, and aims to provide new insights for precise HCC treatment. We also discuss barriers to implementation and suggest solutions for integrating TGS into clinical workflows. This review provides a roadmap for leveraging TGS to revolutionize precision medicine in transplant hepatology.

摘要

肝细胞癌(HCC)是全球癌症相关死亡的主要原因之一。肝移植(LT)仍然是HCC的重要治疗方法,但在患者选择、复发监测和个性化治疗方面仍面临诸多挑战。第三代测序(TGS)具有读长较长、高通量、直接检测表观遗传修饰、实时分析和高精度等优点,为推进肝移植精准医学带来了希望。虽然以往的综述主要关注TGS的技术特征,但本综述独特地综合了其在解决LT-HCC管理中特定临床挑战方面的作用,并对其转化途径进行了批判性评估。具体而言,它系统地研究了TGS在LT-HCC候选者筛选、复发监测和个性化治疗中的应用,分析了其临床转化前景,旨在为精确的HCC治疗提供新见解。我们还讨论了实施障碍,并提出了将TGS整合到临床工作流程中的解决方案。本综述为利用TGS彻底改变移植肝病学中的精准医学提供了路线图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5b/12433387/37b5724134e7/432_2025_6299_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5b/12433387/81cf140ab586/432_2025_6299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5b/12433387/37b5724134e7/432_2025_6299_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5b/12433387/81cf140ab586/432_2025_6299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5b/12433387/37b5724134e7/432_2025_6299_Fig2_HTML.jpg

相似文献

1
Precision medicine in liver transplantation for hepatocellular carcinoma: applications and prospects of third-generation sequencing technology.肝细胞癌肝移植中的精准医学:第三代测序技术的应用与前景
J Cancer Res Clin Oncol. 2025 Sep 13;151(9):257. doi: 10.1007/s00432-025-06299-3.
2
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.等待肝移植的肝细胞癌患者的治疗方法:系统评价和荟萃分析。
Hepatology. 2018 Jan;67(1):381-400. doi: 10.1002/hep.29485. Epub 2017 Nov 29.
3
Prognostic nomogram for recurrence of hepatocellular carcinoma after liver transplantation for decision making on postoperative adjuvant therapy.肝移植后肝细胞癌复发的预后列线图,用于术后辅助治疗的决策制定。
Sci Rep. 2025 Jul 23;15(1):26792. doi: 10.1038/s41598-025-12178-1.
4
Liver transplantation for hepatic tumors: a systematic review.肝脏肿瘤的肝移植:一项系统综述。
World J Gastroenterol. 2014 May 14;20(18):5345-52. doi: 10.3748/wjg.v20.i18.5345.
5
Review Article: Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors.综述文章:免疫检查点抑制剂时代肝细胞癌的肝移植治疗
Aliment Pharmacol Ther. 2025 Sep;62(6):585-601. doi: 10.1111/apt.70333. Epub 2025 Aug 13.
6
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma.个性化且基于肿瘤信息的循环肿瘤DNA检测用于肝细胞癌患者早期复发检测的可行性
JCO Precis Oncol. 2025 Jul;9:e2400934. doi: 10.1200/PO-24-00934. Epub 2025 Jul 2.
7
G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression.G-LERP/miR-374i-b减轻缺血再灌注损伤并抑制肝癌进展。
Transplantation. 2025 Sep 1;109(9):e469-e483. doi: 10.1097/TP.0000000000005412. Epub 2025 May 8.
8
Advancing fungal phylogenetics: integrating modern sequencing, dark taxa discovery, and machine learning.推进真菌系统发育学:整合现代测序、未知类群发现与机器学习
Arch Microbiol. 2025 Jul 11;207(9):192. doi: 10.1007/s00203-025-04392-2.
9
Emerging Trends in Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: A Focus on Liver Transplant Candidates.肝细胞癌新辅助免疫治疗的新趋势:聚焦肝移植候选者
Cancer Rep (Hoboken). 2025 Jul;8(7):e70244. doi: 10.1002/cnr2.70244.
10
[Liver transplantation in patients with hepatocellular carcinoma].[肝细胞癌患者的肝移植]
Korean J Gastroenterol. 2010 Jun;55(6):350-60. doi: 10.4166/kjg.2010.55.6.350.

本文引用的文献

1
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma.个性化且基于肿瘤信息的循环肿瘤DNA检测用于肝细胞癌患者早期复发检测的可行性
JCO Precis Oncol. 2025 Jul;9:e2400934. doi: 10.1200/PO-24-00934. Epub 2025 Jul 2.
2
Updates on Liquid Biopsy and ctDNA in Transplant Oncology.移植肿瘤学中液体活检与循环肿瘤DNA的最新进展
Cancers (Basel). 2025 Jun 10;17(12):1930. doi: 10.3390/cancers17121930.
3
Advancing nanopore technology toward protein identification and sequencing.
推动纳米孔技术用于蛋白质鉴定和测序。
Trends Biochem Sci. 2025 Aug;50(8):721-732. doi: 10.1016/j.tibs.2025.05.005. Epub 2025 Jun 18.
4
Liver transplantation for combined hepatocellular cholangiocarcinoma: Current evidence, selection criteria, and therapeutic controversies.肝细胞胆管癌联合肝移植:当前证据、选择标准及治疗争议
World J Gastrointest Surg. 2025 May 27;17(5):105783. doi: 10.4240/wjgs.v17.i5.105783.
5
Determination of the position of DNA Methylation and Base Modifications Using a Biological Nanopore.利用生物纳米孔确定DNA甲基化和碱基修饰的位置
Small Methods. 2025 Aug;9(8):e2401760. doi: 10.1002/smtd.202401760. Epub 2025 Jun 4.
6
Single-Cell Multi-Omics: Insights into Therapeutic Innovations to Advance Treatment in Cancer.单细胞多组学:对推动癌症治疗进展的治疗创新的见解
Int J Mol Sci. 2025 Mar 9;26(6):2447. doi: 10.3390/ijms26062447.
7
[Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report].[克唑替尼治疗对劳拉替尼耐药的MET扩增、EML4-ALK融合阳性晚期肺腺癌:一例报告]
Zhongguo Fei Ai Za Zhi. 2024 Dec 20;27(12):956-960. doi: 10.3779/j.issn.1009-3419.2024.102.37.
8
Third generation sequencing transforming plant genome research: Current trends and challenges.第三代测序技术变革植物基因组研究:当前趋势与挑战
Gene. 2025 Mar 10;940:149187. doi: 10.1016/j.gene.2024.149187. Epub 2024 Dec 24.
9
VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma.VIM-AS1受CpG甲基化调控,在肝细胞癌中通过EPHA3降解与IGF2BP1协同作用以抑制肿瘤侵袭性。
Exp Mol Med. 2024 Dec;56(12):2617-2630. doi: 10.1038/s12276-024-01352-6. Epub 2024 Dec 2.
10
Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma.用于皮肤T细胞淋巴瘤中T细胞受体重排分析的纳米孔测序
Cancers (Basel). 2024 Nov 1;16(21):3700. doi: 10.3390/cancers16213700.